当前位置: 首页 > 期刊 > 《中国当代医药》 > 2009年第3期
编号:12058225
冠心病治疗进展(5)
http://www.100md.com 2009年1月25日 《中国当代医药》 2009年第3期
     [22]Laurent Bonello,MDSébastien Armero,MD,et al.Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Acute and Subacute Stent Thrombosis[J]. Am J Cardiols.doi:10.1016/j.amjcard, 2008,8:48.

    [23]Aoki J,Nakazawa G,Tanabe K,et al.Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation[J].Catheter Cardiovasc Interv,2007,69(3):380-6.

    [24]Wook-Sung Chung,Chul-Soo Park,Ki-Bae Seung,et al.The incidence and clinical impact of stent strut fractures developed after[J].International Journal of Cardiology,2008,125:325-331.

    [25]Yang T-H. Clinical characteristics of stent fracture after sirolimus-eluting stent implantation[J]. Int J Cardiol (2008),doi:10.1016/j.ijcard,2007,10:59.

    [26]Ko P. Yamada, Tomomi Koizumi,Hiroshi Yamaguchi,et al.Serial angiographic and intravascular ultrasound analysis of late stent strut fracture of sirolimus-eluting stents in native coronary arteries[J].International Journal of Cardiology, 2008,130:255-259.

    [27]Kim JS, Lee SY, Lee JM,et al.Significant association of coronary stent fracture with in-stent restenosis in sirolimus-eluting stents[J].Coron Artery Dis, 2009,20(1):59-63.

    [28]Umeda H. Frequency, predictors and outcome of stent fracture after sirolimus-eluting stent implantation[J] Int J Cardiol (2008) , doi:10.1016/j.ijcard, 2007,12:67.

    (收稿日期:2008-12-24), 百拇医药
上一页1 2 3 4 5